Most bought healthcare stocks in Q1 2023
See which Healthcare stocks institutional investors increased the most in Q1 2023, measured as net growth in reported share positions from Q4 2022 into Q1 2023. Notable additions at the top of this list include GE HEALTHCARE TECHNOLOGY (GEHC), HALEON PLC-ADR (HLN), PFIZER INC (PFE), PRECIGEN INC (PGEN). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| GEHC | GE HEALTHCARE TECHNOLOGY | 21,832,660 | $1.79B | 8 | 0 | 0 | 0 | 8 |
| HLN | HALEON PLC-ADR | 15,727,418 | $139.45M | 0 | 4 | 2 | 1 | 6 |
| PFE | PFIZER INC | 12,779,721 | -$121.39M | 0 | 4 | 6 | 0 | 11 |
| PGEN | PRECIGEN INC | 10,961,369 | $10.08M | 1 | 1 | 0 | 0 | 2 |
| AVTR | AVANTOR INC | 7,329,210 | $87.87M | 3 | 3 | 0 | 1 | 6 |
| CERS | CERUS CORP | 6,636,235 | $7.74M | 0 | 2 | 0 | 0 | 2 |
| BAX | BAXTER INTERNATIONAL INC | 4,377,906 | $88.25M | 1 | 3 | 2 | 0 | 6 |
| NKTR | NEKTAR THERAPEUTICS | 2,886,585 | $1.85K | 0 | 1 | 0 | 0 | 1 |
| ARDX | ARDELYX INC | 2,688,000 | $13.75K | 0 | 1 | 0 | 0 | 1 |
| GSK | GSK PLC-SPON ADR | 2,687,575 | $199.58M | 0 | 4 | 4 | 0 | 8 |
| TDOC | TELADOC HEALTH INC | 2,557,840 | $85.50M | 0 | 2 | 0 | 0 | 2 |
| CVS | CVS HEALTH CORP | 2,507,169 | -$253.15M | 0 | 7 | 1 | 1 | 9 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 2,446,000 | $1.70K | 0 | 1 | 0 | 0 | 1 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 2,061,998 | $111.23M | 0 | 1 | 0 | 0 | 1 |
| CTLT | CATALENT INC | 2,060,318 | $175.76M | 2 | 1 | 1 | 1 | 4 |
| ELAN | ELANCO ANIMAL HEALTH INC | 1,887,060 | -$239.77M | 0 | 1 | 2 | 0 | 3 |
| VKTX | VIKING THERAPEUTICS INC | 1,765,663 | $32.56M | 1 | 0 | 1 | 0 | 2 |
| ALHC | ALIGNMENT HEALTHCARE INC | 1,763,712 | -$9.89M | 0 | 2 | 0 | 0 | 2 |
| OPCH | OPTION CARE HEALTH INC | 1,628,727 | $36.39M | 2 | 1 | 0 | 0 | 3 |
| CNC | CENTENE CORP | 1,422,984 | $53.96M | 1 | 1 | 1 | 0 | 3 |
| ASRT | ASSERTIO HOLDINGS INC | 1,357,279 | $2.53M | 0 | 2 | 0 | 0 | 2 |
| CMPS | COMPASS PATHWAYS PLC | 1,146,496 | $15.34M | 0 | 1 | 1 | 0 | 2 |
| BHC | BAUSCH HEALTH COS INC | 1,134,573 | $1.41M | 1 | 0 | 1 | 0 | 4 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,113,299 | -$965 | 0 | 1 | 0 | 0 | 1 |
| ERAS | ERASCA INC | 1,103,115 | $2.86K | 0 | 1 | 0 | 0 | 1 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 1,035,658 | $8.82K | 0 | 1 | 0 | 0 | 1 |
| DHR | DANAHER CORP | 1,033,740 | -$96.57M | 0 | 5 | 5 | 0 | 12 |
| PLX | PROTALIX BIOTHERAPEUTICS INC | 985,147 | $2.23K | 0 | 1 | 0 | 0 | 1 |
| CDNA | CAREDX INC | 944,149 | -$6.78M | 0 | 3 | 0 | 0 | 3 |
| BMY | BRISTOL-MYERS SQUIBB CO | 907,851 | -$30.07M | 0 | 3 | 5 | 3 | 10 |
| MRK | MERCK & CO. INC. | 903,933 | -$24.77M | 0 | 3 | 6 | 0 | 12 |
| ME | 23ANDME HOLDING CO -CLASS A | 890,909 | -$48.80K | 0 | 1 | 0 | 1 | 1 |
| OCGN | OCUGEN INC | 858,692 | $96 | 0 | 1 | 0 | 0 | 1 |
| HRTX | HERON THERAPEUTICS INC | 814,336 | $907 | 0 | 1 | 0 | 0 | 1 |
| CDXS | CODEXIS INC | 802,701 | -$584.24K | 0 | 2 | 0 | 0 | 2 |
| INCY | INCYTE CORP | 778,550 | -$181.98M | 0 | 1 | 2 | 1 | 3 |
| THC | TENET HEALTHCARE CORP | 776,199 | $54.50M | 0 | 2 | 0 | 0 | 2 |
| NVAX | NOVAVAX INC | 718,700 | -$4.47K | 0 | 1 | 0 | 0 | 1 |
| CMRX | CHIMERIX INC | 708,976 | $499 | 0 | 1 | 0 | 0 | 1 |
| RXRX | RECURSION PHARMACEUTICALS-A | 699,033 | -$38.12K | 0 | 2 | 0 | 0 | 2 |
| ABCL | ABCELLERA BIOLOGICS INC | 689,100 | -$301 | 0 | 1 | 0 | 0 | 1 |
| MRSN | MERSANA THERAPEUTICS INC | 678,800 | $1.79K | 0 | 1 | 0 | 0 | 1 |
| KZR | KEZAR LIFE SCIENCES INC | 612,584 | $1.59K | 0 | 1 | 0 | 0 | 1 |
| TVTX | TRAVERE THERAPEUTICS INC | 551,300 | $14.72K | 0 | 1 | 0 | 0 | 1 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 546,400 | $2.22K | 0 | 1 | 0 | 0 | 1 |
| EWTX | EDGEWISE THERAPEUTICS INC | 519,200 | -$6.67M | 0 | 2 | 0 | 0 | 2 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 479,282 | $1.78M | 0 | 2 | 0 | 0 | 2 |
| TWST | TWIST BIOSCIENCE CORP | 478,257 | -$51.29M | 0 | 1 | 0 | 0 | 1 |
| ACCD | ACCOLADE INC | 471,696 | $40.00M | 0 | 2 | 0 | 0 | 2 |
| ILMN | ILLUMINA INC | 468,556 | $165.90M | 1 | 3 | 0 | 0 | 4 |
Frequently asked questions about Most bought healthcare stocks in Q1 2023
What are the most bought Healthcare stocks in Q1 2023?
The most bought healthcare stocks in Q1 2023 are those with the largest increase in reported share counts across tracked institutional investors compared to Q4 2022, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2023?
Among the managers we track, net additions were largest in companies such as GE HEALTHCARE TECHNOLOGY (GEHC), HALEON PLC-ADR (HLN), PFIZER INC (PFE), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q4 2022).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.